<IPO>MediLink Therapeutics Hires Multiple Brokers for USD100M+ HK IPO: Wire
MediLink Therapeutics, a biotech company headquartered in Suzhou, has hired CICC, JPMorgan, and M...
MediLink Therapeutics, a biotech company headquartered in Suzhou, has hired CICC, JPMorgan, and Morgan Stanley to prepare for its planned Hong Kong IPO, which aims to raise over USD100 million, Bloomberg reported, citing sources.
The company was founded in 2020. As a clinical-stage biotech firm, it focuses on antibody drugs with R&D centers in both Shanghai and Boston.
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.